<VariationArchive VariationID="6385" VariationName="NM_198239.2(CCN6):c.862_863dup (p.Gln289fs)" VariationType="Duplication" Accession="VCV000006385" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2015-09-17" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21424" VariationID="6385">
      <GeneList>
        <Gene Symbol="CCN6" FullName="cellular communication network factor 6" GeneID="8838" HGNC_ID="HGNC:12771" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="112052813" stop="112069686" display_start="112052813" display_stop="112069686" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="112375277" stop="112390888" display_start="112375277" display_stop="112390888" Strand="+" />
          </Location>
          <OMIM>603400</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198239.2(CCN6):c.862_863dup (p.Gln289fs)</Name>
      <CanonicalSPDI>NC_000006.12:112069416:AC:ACAC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="112069416" stop="112069417" display_start="112069416" display_stop="112069417" variantLength="2" positionVCF="112069416" referenceAlleleVCF="T" alternateAlleleVCF="TAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="112390619" stop="112390620" display_start="112390619" display_stop="112390620" variantLength="2" positionVCF="112390619" referenceAlleleVCF="T" alternateAlleleVCF="TAC" />
      </Location>
      <ProteinChange>Q289fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.112390620_112390621dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.112390620_112390621dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.112069417_112069418dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.112069417_112069418dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011748.1" sequenceAccession="NG_011748" sequenceVersion="1" change="g.20343_20344dup">
            <Expression>NG_011748.1:g.20343_20344dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003880.4" sequenceAccession="NM_003880" sequenceVersion="4" change="c.862_863dup">
            <Expression>NM_003880.4:c.862_863dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003871.1" sequenceAccession="NP_003871" sequenceVersion="1" change="p.Gln289fs">
            <Expression>NP_003871.1:p.Gln289fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198239.2" sequenceAccession="NM_198239" sequenceVersion="2" change="c.862_863dup" MANESelect="true">
            <Expression>NM_198239.2:c.862_863dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_937882.2" sequenceAccession="NP_937882" sequenceVersion="2" change="p.Gln289fs">
            <Expression>NP_937882.2:p.Gln289fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_125353.2" sequenceAccession="NR_125353" sequenceVersion="2" change="n.1180_1181dup">
            <Expression>NR_125353.2:n.1180_1181dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_125354.3" sequenceAccession="NR_125354" sequenceVersion="3" change="n.1007_1008dup">
            <Expression>NR_125354.3:n.1007_1008dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003880.3" sequenceAccession="NM_003880" sequenceVersion="3" change="c.862_863dupAC">
            <Expression>NM_003880.3:c.862_863dupAC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA278864" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603400.0007" DB="OMIM" />
        <XRef Type="rs" ID="863223286" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00005" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00006" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00007" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198239.2(CCN6):c.862_863dup (p.Gln289fs) AND Progressive pseudorheumatoid dysplasia" Accession="RCV000006757" Version="6">
        <ClassifiedConditionList TraitSetID="1769">
          <ClassifiedCondition DB="MedGen" ID="C0432215">Progressive pseudorheumatoid dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198239.2(CCN6):c.862_863dup (p.Gln289fs) AND CCN6-related disorder" Accession="RCV003415669" Version="4">
        <ClassifiedConditionList TraitSetID="91803">
          <ClassifiedCondition>CCN6-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198239.2(CCN6):c.862_863dup (p.Gln289fs) AND not provided" Accession="RCV002512851" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-03" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-09-17" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10471507</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22791401</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29258992</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="91803" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69443" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CCN6-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CCN6-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="1769" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4623" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Progressive pseudorheumatoid dysplasia</ElementValue>
                <XRef ID="Spondyloepiphyseal+dysplasia+tarda+progressive+arthropathy/6826" DB="Genetic Alliance" />
                <XRef ID="254065005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive spondyloepiphyseal dysplasia tarda</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY</ElementValue>
                <XRef Type="MIM" ID="208230" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive Pseudorheumatoid Arthropathy of Childhood</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spondyloepiphyseal dysplasia tarda progressive arthropathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPRD</ElementValue>
                <XRef Type="MIM" ID="208230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PPD</ElementValue>
                <XRef Type="MIM" ID="208230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SEDT-PA</ElementValue>
                <XRef Type="MIM" ID="208230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Progressive pseudorheumatoid dysplasia (PPD) is a skeletal dysplasia characterized by predominant involvement of articular cartilage with progressive joint stiffness and enlargement in the absence of inflammation. Onset – typically between ages three and six years – begins with the involvement of the interphalangeal joints. Over time, involvement of large joints and the spine causes significant joint contractures, gait disturbance, and scoliosis and/or kyphosis, resulting in abnormal posture and significant morbidity. Despite the considerable arthropathy, pain is not a major presenting feature of this condition. Initially height is normal; however, short stature (&lt;3rd centile) becomes evident in adolescence as the skeletal changes progress.</Attribute>
                <XRef ID="NBK327267" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9184" />
                <XRef ID="9184" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000561819" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556388" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26610319</ID>
                <ID Source="BookShelf">NBK327267</ID>
              </Citation>
              <XRef ID="1159" DB="Orphanet" />
              <XRef ID="C0432215" DB="MedGen" />
              <XRef ID="MONDO:0008827" DB="MONDO" />
              <XRef Type="MIM" ID="208230" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6146850" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4016424|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003458427" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10471507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22791401</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10471507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22791401</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29258992</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gln289Leufs*25) in the WISP3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acid(s) of the WISP3 protein. This variant is present in population databases (rs782611561, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with progressive pseudorheumatoid dysplasia (PMID: 10471507, 22791401). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as 863insAC. ClinVar contains an entry for this variant (Variation ID: 6385). This variant disrupts a region of the WISP3 protein in which other variant(s) (p.Ser290Leufs*12) have been determined to be pathogenic (PMID: 10471507, 22791401, 29258992). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCN6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.112390619_112390620insAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="26949" SubmissionDate="2020-10-08" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603400.0007_PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY" title="CCN6, 2-BP INS, 863AC_PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY" />
        <ClinVarAccession Accession="SCV000026949" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family from the United States with progressive pseudorheumatoid arthropathy (PPRD; 208230), Hurvitz et al. (1999) found compound heterozygous mutations in the WISP3 gene: a 2-bp insertion at nucleotide 863, resulting in a frameshift at residue 288 with a stop 24 residues downstream, and 2-bp deletion at nucleotide 43 (43_44delGC; 603400.0008), resulting in a frameshift at residue 15 with a stop 15 residues downstream.</Attribute>
              <Citation>
                <ID Source="PubMed">10471507</ID>
              </Citation>
              <XRef DB="OMIM" ID="208230" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCN6" />
          </GeneList>
          <Name>CCN6, 2-BP INS, 863AC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP INS, 863AC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603400.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7698154" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="16563245|CCN6-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004114112" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CCN6 c.862_863dupAC variant is predicted to result in a frameshift and premature protein termination (p.Gln289Leufs*25). This variant was reported in an individual with progressive pseudorheumatoid dysplasia (described as c.863insAC, Hurvitz et al 1999. PubMed ID: 10471507). This variant is reported in 0.010% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-112390619-T-TAC). Frameshift variants in CCN6 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCN6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003880.3:c.862_863dupAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CCN6-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7698154" TraitType="Disease" MappingType="Name" MappingValue="CCN6-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="CCN6-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26949" TraitType="Disease" MappingType="Name" MappingValue="PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY" MappingRef="Preferred">
        <MedGen CUI="C0432215" Name="Progressive pseudorheumatoid dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6146850" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

